We use the most advanced technology to perform genetic testings which detect both, pathogenetic mutations in responsibles genes of neoplastic diseases, and structural genetic variations which may be involved in these diseases.
Together with the results of the requested analysis, WG produces a clinical report which pretends to support the oncologist with the choice of the most adequate treatment for a given patient. It suggest which drug classes may be more adequate or less adequate for a that genetic profile. In summary, it informs how the patient can react to a given treatment.
Check out our portfolio for more information!
